We first retested the PERSI method in a cohort that underwent PET imaging with flortaucipir as the tau tracer (Cohort I, including healthy controls [HCs] and patients with mild cognitive impairment [MCI] and AD), which has been previously reported. Here, MAPT is linked to Alzheimer disease.